Cancan Diagnostic Debuts Revolutionary Canine MRD Cancer Testing Solution

Latest Comments
No comments to show.

Tags:

Cancan Diagnostic is delighted to announce the launch of K9-LiquiDX, marking the advent of the first-ever Minimal Residual Disease (MRD) test engineered specifically for dogs. Set to be released on March 5, 2024, K9-LiquiDX embodies a significant stride in veterinary oncology, equipping vets and pet owners with an advanced tool for the early detection of cancer relapse and meticulous disease…

Source

Categories

No responses yet

Leave a Reply

Your email address will not be published.